Reciprocal Induction of MDM2 and MYCN in Neural and Neuroendocrine Cancers

Hung N Tran1, Hardeep P Singh2,3,4, Wenxuan Guo2,3,5

  • 1Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, CA, United States.

Frontiers in Oncology
|January 11, 2021
PubMed

Insights

MDM2 protein specifically promotes MYCN expression in several cancers, forming an oncogenic feedback loop. This collaboration is essential for tumor growth and originates in normal neuronal tissue.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • MYC family oncoproteins (MYC, MYCN, MYCL) are frequently deregulated in various cancers.
  • MDM2 (mouse double minute 2 homolog) oncoprotein promotes MYCN translation and proliferation independently of p53 in retinoblastoma and neuroblastoma.
  • The roles of MDM2 in regulating other MYC family members and its involvement in tumorigenesis remain unclear.

Purpose of the Study:

  • To investigate if MDM2 regulates other MYC family members beyond MYCN.
  • To determine if MYC family proteins upregulate MDM2 expression in various cancers and during tumorigenesis.
  • To elucidate the specific collaboration between MDM2 and MYC/MYCN oncoproteins.

Main Methods:

  • Analysis of MDM2 and MYCN expression in retinoblastoma, neuroblastoma, small cell lung cancer, and medulloblastoma cell lines.
  • Overexpression studies of MYC and MYCN in a cultured retinoblastoma genesis model.
  • Assessment of MDM2 dependency for proliferation in induced tumor masses.

Main Results:

  • Intrinsically high MDM2 expression is crucial for high-level MYCN expression, but not MYC, across multiple cancer types.
  • Ectopic MYC and MYCN overexpression induce high-level MDM2 expression.
  • Induced MYC/MYCN overexpression leads to rapid proliferation and MDM2-dependent tumor formation in a retinoblastoma genesis model.

Conclusions:

  • MDM2 and MYCN oncoproteins exhibit a highly specific collaborative relationship.
  • An oncogenic positive feedback circuit between MDM2 and MYCN originates within normal neuronal tissue.
  • This specific interaction is a key driver in certain malignancies, particularly those involving MYCN.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.4K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.6K